In VitroFunctional and Immunomodulatory Properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 Association That Are Relevant to the Development of a Pharyngeal Probiotic Product
Open Access
- 15 June 2012
- journal article
- research article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 78 (12), 4209-4216
- https://doi.org/10.1128/aem.00325-12
Abstract
The use of proper bacterial strains as probiotics for the pharyngeal mucosa is a potential prophylactic strategy for upper respiratory tract infections. In this context, we characterized in vitro the functional and immunomodulatory properties of the strains Lactobacillus helveticus MIMLh5 and Streptococcus salivarius ST3 that were selected during previous investigations as promising pharyngeal probiotics. In this study, we demonstrated in vitro that strains MIMLh5 and ST3, alone and in combination, can efficiently adhere to pharyngeal epithelial cells, antagonize Streptococcus pyogenes, and modulate host innate immunity by inducing potentially protective effects. In particular, we found that the strains MIMLh5 and ST3 activate U937 human macrophages by significantly inducing the expression of the proinflammatory cytokine tumor necrosis factor alpha (TNF-α). Nonetheless, the induction of the anti-inflammatory interleukin-10 (IL-10) by MIMLh5 or ST3 was never lower than that of TNF-α, suggesting that these bacteria can potentially exert a regulatory rather than a proinflammatory effect. We also found that the strains MIMLh5 and ST3 induce cyclooxygenase 2 (COX-2) expression and demonstrated that toll-like receptor 2 (TLR-2) participates in the recognition of the strains MIMLh5 and ST3 by U937 cells. Finally, we observed that these microorganisms grow efficiently when cocultured in milk, suggesting that the preparation of a milk-based fermented product containing both MIMLh5 and ST3 can be a practical solution for the administration of these bacteria. In conclusion, we propose the combined use of L. helveticus MIMLh5 and S. salivarius ST3 for the preparation of novel products that display probiotic properties for the pharyngeal mucosa.Keywords
This publication has 51 references indexed in Scilit:
- Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- A Dairy Bacterium Displays I n V itro Probiotic Properties for the Pharyngeal Mucosa by Antagonizing Group A Streptococci and Modulating the Immune ResponseInfection and Immunity, 2010
- Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll‐like receptor‐2‐dependent mechanismImmunology, 2010
- Oral Bacteria as Potential Probiotics for the Pharyngeal MucosaApplied and Environmental Microbiology, 2010
- Generation of regulatory dendritic cells and CD4 + Foxp3 + T cells by probiotics administration suppresses immune disordersProceedings of the National Academy of Sciences of the United States of America, 2010
- Peptidoglycan from lactobacilli inhibits interleukin‐12 production by macrophages induced by Lactobacillus casei through Toll‐like receptor 2‐dependent and independent mechanismsImmunology, 2009
- The Commensal Streptococcus salivarius K12 Downregulates the Innate Immune Responses of Human Epithelial Cells and Promotes Host-Microbe HomeostasisInfection and Immunity, 2008
- Toll‐like receptor 2 and nucleotide‐binding oligomerization domain‐2 play divergent roles in the recognition of gut‐derived lactobacilli and bifidobacteria in dendritic cellsImmunology, 2008
- Production of the Lantibiotic Salivaricin A and Its Variants by Oral Streptococci and Use of a Specific Induction Assay To Detect Their Presence in Human SalivaApplied and Environmental Microbiology, 2006
- Interaction of lactic acid bacteria with the gut immune systemEuropean Journal of Clinical Nutrition, 2002